Finally, also in the multivariate analysis, bDMARDs failed to reach statistical significance as a protective factor on the development of SpA throughout the whole follow-up (p=0.05 and p=0.16, respectively) ( table 2 , figure 3 ).
← all excerpts
Impact of biological therapy in reducing the risk of arthritis development in inflammatory bowel diseases.
1
0.0500
0.0500